Senior Medical Scientist - Cardio Intercontinental Region

Employer
Amgen
Location
Thousand Oaks, California
Posted
Aug 31, 2018
Ref
R-62460
Required Education
Doctorate/PHD/MD
Position Type
Full time

The Senior Medical Scientist - Cardiovascular - Intercontinental Region (IC)* supports the creation and implementation of the cross-functional regional medical strategy, medical communication plan, scientific engagement plan and evidence generation in the cardiology therapeutic area.

*Intercontinental Region (IC) is represented by 3 sub-geographies: Canada, Latin-America and TMEA (Turkey, Middle East and Africa)

Responsibilities:

· Supporting the development and execution of regional product medical strategy, via the Regional Medical Plan, including launch support and lifecycle management, in collaboration with Product Team/Portfolio

· Governance and alignment with Global strategy

· Supporting definition of scientific evidence gaps, development of local evidence generation strategy in coordination with Global

· Supporting clinical trial conduct

· Participating in engagement of external key stakeholders (often in partnership with other functions)

· Participating in development of data communication strategy (including congress)

· Supports Medical input into label and regulatory interactions, in alignment and with deep understanding of global strategy and program clinical trial data

· Supports implementation of Medical governance for respective product

Key Activities:

· Maximizes Amgen's value proposition of respective product(s) through management and delivery of all medical and scientific activities, including launch and lifecycle management, in alignment with Global strategy and Evidence Generation Team (EGT)

· Participates in development of the IC cross-functional strategy and supports medical execution.

· Provides input into medical and scientific insight for incorporation into IC product strategies, via the IC Medical Plan, and provides insights into Global strategies, plans and tactics as a participant in the Commercialization process

· Ensures understanding and incorporation of patient perspectives in all activities

· Executes product-specific IC evidence generation strategy, in alignment with EGT, and supports execution of data communication strategy

· Supports product-specific IC clinical trial execution

· Medical / Scientific contribution to Value Dossiers, compendia and interactions with payers in collaboration with VA&P

· Medical input into label and regulatory interactions, in alignment and with deep understanding of global strategy and program clinical trial data

· May participate in speaking engagements that represent Amgen to external and internal bodies on medical and scientific issues related to relevant product(s)

· Supports or implements external Stakeholder Strategy

· Engagement strategy and execution with medical experts, professional societies, patient groups and other key stakeholders

· Participates in advocacy from a medical perspective in partnership with Commercial, Government Affairs and GRAAS policy

· Builds Amgen's reputation as a science-based and patient-focused reliable partner

· Ensures Medical Governance

· Ensures human subject safety for marketed product in cooperation and effective partnership with responsible functions (e.g. GRAAS, Global Development)

· May support IC clinical trial conduct (Interventional and observational studies - Implementation Science)

· Actively participates in IC risk management/minimization in collaboration with GRAAS

· Ensures appropriate medical leadership of compliance; accountable for the conduct of medical activities according to all relevant compliance standards, regulations and SOP`s; Role models appropriate and compliant behaviors and contributes to creating a climate of compliance adherence across the organization

Basic Qualifications

MD, DO, PhD or PharmD with 2 years of medical affairs experience

Preferred Qualifications

· 1 years from a pharmaceutical or biotechnology company

· Therapeutic area expertise: Cardiology (Focus on dyslipidemia)

· Broad and formal leadership experience

· Clinical research/medical affairs experience in the biopharmaceutical industry (biotech, pharmaceutical or CRO)